Bristol-Myers Settles Plavix Securities Suit For $125M
Bristol-Myers Squibb Co. has reported a $125 million settlement in a securities class action that accuses the drugmaker of duping shareholders and causing a stock drop when it failed to properly...To view the full article, register now.
Already a subscriber? Click here to view full article